Alpha 2.0
Login Register
» Articles » PMID: 5309476

Protection Against Hong Kong Influneza by Adjuvant Vaccine Containing A2-Ann Arbor-67

Overview
Journal Bull World Health Organ
Specialty Public Health
Date 1969 Jan 1
PMID 5309476
Citations 7
Authors
T C Eickhoff
G MEIKLEJOHN
Affiliations
Soon will be listed here.
Citing Articles

The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.

Catani J, Smet A, Ysenbaert T, Vuylsteke M, Bottu G, Mathys J Elife. 2024; 12.

PMID: 38805550 PMC: 11132685. DOI: 10.7554/eLife.90782.

Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine.

Giurgea L, Morens D, Taubenberger J, Memoli M Vaccines (Basel). 2020; 8(3).

PMID: 32718039 PMC: 7564061. DOI: 10.3390/vaccines8030409.

Influenza vaccines: from surveillance through production to protection.

Tosh P, Jacobson R, Poland G Mayo Clin Proc. 2010; 85(3):257-73.

PMID: 20118381 PMC: 2843114. DOI: 10.4065/mcp.2009.0615.

Towards a sane and rational approach to management of Influenza H1N1 2009.

Gallaher W Virol J. 2009; 6:51.

PMID: 19422701 PMC: 2691743. DOI: 10.1186/1743-422X-6-51.

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

Sandbulte M, Jimenez G, Boon A, Smith L, Treanor J, Webby R PLoS Med. 2007; 4(2):e59.

PMID: 17298168 PMC: 1796909. DOI: 10.1371/journal.pmed.0040059.